Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review
Authors
Keywords
Reference Price, Pharmaceutical Benefit Advisory Committee, Restricting Treatment, Benfluorex, Coverage With Evidence Development
Journal
PHARMACOECONOMICS
Volume 33, Issue 9, Pages 905-924
Publisher
Springer Nature
Online
2015-06-05
DOI
10.1007/s40273-015-0293-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prescribing efficiency of proton pump inhibitors in China: influence and future directions
- (2015) Wenjie Zeng et al. BMC HEALTH SERVICES RESEARCH
- Managed entry agreements for pharmaceuticals in Australia
- (2014) Agnes Vitry et al. HEALTH POLICY
- Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development
- (2014) K Claxton et al. HEALTH TECHNOLOGY ASSESSMENT
- Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
- (2014) Brian Godman et al. Expert Review of Clinical Pharmacology
- Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction
- (2014) Wenjie Zeng et al. Journal of Comparative Effectiveness Research
- Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review
- (2014) Ana Luísa Caires de Souza et al. Applied Health Economics and Health Policy
- HEALTH TECHNOLOGY REASSESSMENT: THE ART OF THE POSSIBLE
- (2013) Gail MacKean et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- CASE STUDIES THAT ILLUSTRATE DISINVESTMENT AND RESOURCE ALLOCATION DECISION-MAKING PROCESSES IN HEALTH CARE: A SYSTEMATIC REVIEW
- (2013) Julie Polisena et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force
- (2013) Louis P. Garrison et al. VALUE IN HEALTH
- The impacts of health insurance on health care utilization among the older people in China
- (2013) Xin Li et al. SOCIAL SCIENCE & MEDICINE
- Does perverse economic incentive lead to the irrational uses of medicines?
- (2013) Wenhui Mao et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries
- (2013) Brian Godman et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Measures to improve angiotensin receptor blocker prescribing efficiency in the UK: findings and implications
- (2013) Andrew Martin et al. Journal of Comparative Effectiveness Research
- The reform of the essential medicines system in China: a comprehensive approach to universal coverage
- (2013) Sarah L. Barber et al. Journal of Global Health
- Ongoing pharmaceutical reforms in France
- (2013) Catherine Sermet et al. Applied Health Economics and Health Policy
- Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France
- (2013) Sylvain Pichetti et al. Applied Health Economics and Health Policy
- Breaking up is hard to do: why disinvestment in medical technology is harder than investment
- (2012) Marion Haas et al. Australian Health Review
- Controlling cost escalation of healthcare: making universal health coverage sustainable in China
- (2012) Shenglan Tang et al. BMC PUBLIC HEALTH
- International variability in the reimbursement of cancer drugs by publically funded drug programs
- (2012) P. K. Cheema et al. Current Oncology
- Overprescribing In China, Driven By Financial Incentives, Results In Very High Use Of Antibiotics, Injections, And Corticosteroids
- (2012) Yongbin Li et al. HEALTH AFFAIRS
- A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security
- (2012) Lionel Riou França et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Financial burden of household out-of pocket health expenditure in Viet Nam: Findings from the National Living Standard Survey 2002–2010
- (2012) Hoang Van Minh et al. SOCIAL SCIENCE & MEDICINE
- NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium
- (2012) John A Ford et al. BMJ Open
- Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: A time-series analysis for France 1998–2010
- (2011) Sylvain Pichetti et al. HEALTH POLICY
- High prices for generics in Australia — more competition might help
- (2010) Liliana Bulfone Australian Health Review
- Generic and therapeutic substitutions in the UK: are they a good thing?
- (2010) Martin G. Duerden et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers
- (2010) Josh J. Carlson et al. HEALTH POLICY
- Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey
- (2010) Anita K. Wagner et al. HEALTH POLICY
- Funding the Unfundable
- (2010) Tania Stafinski et al. PHARMACOECONOMICS
- Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus
- (2010) Alain Weill et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications
- (2010) Diane McGinn et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
- (2010) Brian Godman et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Health Technology Assessment: Lessons Learned from Around the World—An Overview
- (2009) John C. O'Donnell et al. VALUE IN HEALTH
- Applying Programme Budgeting Marginal Analysis in the health sector: 12 years of experience
- (2009) Rachel Grocott Expert Review of Pharmacoeconomics & Outcomes Research
- Enhancing the rational use of new medicines across European health care systems
- (2008) Silvio Garattini et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmaceutical Policy In China
- (2008) Qiang Sun et al. HEALTH AFFAIRS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now